Adam M Veness - Net Worth and Insider Trading

Adam M Veness Net Worth

The estimated net worth of Adam M Veness is at least $3 Million dollars as of 2024-06-03. Adam M Veness is the SVP, General Counsel and Sec. of Acceleron Pharma Inc and owns about 18,923 shares of Acceleron Pharma Inc (XLRN) stock worth over $3 Million. Details can be seen in Adam M Veness's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Adam M Veness has not made any transactions after 2021-09-21 and currently still holds the listed stock(s).

Transaction Summary of Adam M Veness

To

Adam M Veness Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Adam M Veness owns 3 companies in total, including Acceleron Pharma Inc (XLRN) , Cyteir Therapeutics Inc (CYTT) , and Magenta Therapeutics Inc (MGTA) .

Click here to see the complete history of Adam M Veness’s form 4 insider trades.

Insider Ownership Summary of Adam M Veness

Ticker Comapny Transaction Date Type of Owner
XLRN Acceleron Pharma Inc 2021-09-21 SVP & General Counsel and Sec.
CYTT Cyteir Therapeutics Inc 2022-04-25 General Counsel
MGTA Magenta Therapeutics Inc 2023-09-11 See Remarks

Adam M Veness Latest Holdings Summary

Adam M Veness currently owns a total of 1 stock. Adam M Veness owns 18,923 shares of Acceleron Pharma Inc (XLRN) as of September 21, 2021, with a value of $3 Million.

Latest Holdings of Adam M Veness

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XLRN Acceleron Pharma Inc 2021-09-21 18,923 178.75 3,382,486

Holding Weightings of Adam M Veness


Adam M Veness Form 4 Trading Tracker

According to the SEC Form 4 filings, Adam M Veness has made a total of 9 transactions in Acceleron Pharma Inc (XLRN) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Acceleron Pharma Inc is the sale of 6,650 shares on September 21, 2021, which brought Adam M Veness around $997,832.

Insider Trading History of Adam M Veness

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Adam M Veness Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Adam M Veness Ownership Network

Ownership Network List of Adam M Veness

No Data

Ownership Network Relation of Adam M Veness

Insider Network Chart

Adam M Veness Owned Company Details

What does Acceleron Pharma Inc do?

Who are the key executives at Acceleron Pharma Inc?

Adam M Veness is the SVP & General Counsel and Sec. of Acceleron Pharma Inc. Other key executives at Acceleron Pharma Inc include EVP & Chief Commercial Officer Sujay Kango , SVP & CFO and Treasurer Kevin F Mclaughlin , and director & CEO and President Habib J Dable .

Acceleron Pharma Inc (XLRN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acceleron Pharma Inc (XLRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acceleron Pharma Inc (XLRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acceleron Pharma Inc (XLRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acceleron Pharma Inc Insider Transactions

No Available Data

Adam M Veness Mailing Address

Above is the net worth, insider trading, and ownership report for Adam M Veness. You might contact Adam M Veness via mailing address: C/o Dianthus Therapeutics, Inc., 7 Times Square, 43rd Floor, New York Ny 10036.

Discussions on Adam M Veness

No discussions yet.